v3.26.1
Share-Based Compensation (Tables)
6 Months Ended
Jun. 30, 2026
Share-Based Payment Arrangement [Abstract]  
Schedule of Assumptions Used in Estimating the Fair Value of Option Grants Issued and Fair Value of Common Stock to be Purchased under 2026 ESPP The following assumptions were used in estimating the fair value of option grants issued:

 

 

 

Three Months Ended

 

Six Months Ended

 

 

June 30,

 

June 30,

 

 

2026

 

2025

 

2026

 

2025

Expected term (years)

 

5.6 — 6.1

 

4.9 — 6.1

 

5.6 — 6.1

 

3.3 — 6.1

Volatility

 

58.6% — 58.9%

 

51.5% — 52.0%

 

58.6% — 81.9%

 

51.5% — 52.9%

Risk-free interest rate

 

4.1% — 4.2%

 

3.8% — 4.0%

 

4.0% — 4.2%

 

3.8% — 4.2%

Dividend yield

 

 

 

 

The following assumptions were used to estimate the fair value of common stock to be purchased under the 2026 Employee Stock Purchase Plan (ESPP) in 2026:

 

 

 

Three Months Ended

 

Six Months Ended

 

 

June 30,

 

June 30,

 

 

2026

 

2026

Expected term (years)

 

0.5

 

0.5

Volatility

 

53.4%

 

53.4%

Risk-free interest rate

 

3.7%

 

3.7%

Dividend yield

 

 

Schedule of Stock Options Activity

Stock options — A summary of stock options activity under the 2007, 2022, and 2026 Plans is presented below (in thousands, except for share and per share amounts):

 

 

 

Options Outstanding

 

 

 

 

 

 

 

 

Number of Options

 

 

Weighted Average Exercise Price

 

 

Weighted Average Remaining Contractual Term (in years)

 

Aggregate Intrinsic Value

 

Outstanding as of December 31, 2025

 

 

4,046,266

 

 

$

3.51

 

 

7.90

 

$

1,611

 

Options Granted

 

 

3,396,740

 

 

$

13.83

 

 

 

 

 

 

Options Exercised

 

 

(172,402

)

 

$

3.14

 

 

 

 

 

 

Options Forfeited, Cancelled, or Expired

 

 

(98,129

)

 

$

4.78

 

 

 

 

 

 

Outstanding as of June 30, 2026

 

 

7,172,475

 

 

$

8.41

 

 

8.73

 

$

40,124

 

Vested and exercisable at June 30, 2026

 

 

2,014,642

 

 

$

3.39

 

 

6.35

 

$

20,159

 

Summary of Stock Options Outstanding Exercise Price Range

The following table summarizes information about stock options outstanding as of June 30, 2026:

 

 

 

Options Outstanding

 

Options Vested

 

 

 

 

 

 

Weighted Average

 

 

 

 

 

 

 

 

 

 

Remaining

 

 

 

 

 

 

Number of

 

Weighted Average

 

Contractual Term

 

Number of

 

Weighted Average

Exercise Price

 

Shares

 

Exercise Price

 

(in years)

 

Shares

 

Exercise Price

$1.40

 

22,969

 

$1.40

 

3.35

 

22,969

 

$1.40

$2.66

 

61,727

 

$2.66

 

4.20

 

61,727

 

$2.66

$2.79

 

84,409

 

$2.79

 

2.53

 

84,409

 

$2.79

$2.88

 

43,066

 

$2.88

 

4.83

 

43,066

 

$2.88

$3.24

 

240,178

 

$3.24

 

7.98

 

124,573

 

$3.24

$3.38

 

1,181,973

 

$3.38

 

6.54

 

1,108,237

 

$3.38

$3.42

 

31,812

 

$3.42

 

7.27

 

21,583

 

$3.42

$3.73

 

1,498,215

 

$3.73

 

8.64

 

511,124

 

$3.73

$3.94

 

522,702

 

$3.94

 

9.32

 

 

$3.94

$4.11

 

99,604

 

$4.11

 

8.75

 

36,954

 

$4.11

$7.91

 

524,180

 

$7.91

 

9.73

 

 

$7.91

$13.50

 

182,800

 

$13.50

 

9.93

 

 

$13.50

$15.00

 

2,678,840

 

$15.00

 

9.86

 

 

$15.00

$1.40 — $15.00

 

7,172,475

 

$8.41

 

8.73

 

2,014,642

 

$3.39

Summary of Restricted Stock Units

Restricted stock units A summary of officer, employee, and non-employee restricted stock units granted and outstanding, under the 2026 Plan is presented below (in thousands, except for share and per share amounts):

 

 

 

Number of Restricted Stock Units

 

 

Weighted Average Grant Date Fair Value

 

 

Aggregate Intrinsic Value

 

Outstanding as of December 31, 2025

 

 

 

 

 

 

 

 

 

Restricted Stock Units Granted

 

 

181,560

 

 

$

15.00

 

 

 

 

Restricted Stock Units Forfeited, Cancelled, or Expired

 

 

(2,000

)

 

$

15.00

 

 

 

 

Outstanding as of June 30, 2026

 

 

179,560

 

 

$

15.00

 

 

$

2,406

 

Expected to vest as of June 30, 2026

 

 

179,560

 

 

$

15.00

 

 

$

2,406

 

Summary of Share-Based Compensation Expense hare-based compensation expense recognized in the condensed statements of operations was classified as follows (in thousands):

 

 

 

Three Months Ended

 

 

Six Months Ended

 

 

 

June 30,

 

 

June 30,

 

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

Research and development costs

 

$

210

 

 

$

 

 

$

278

 

 

$

 

Selling, general and administrative expenses

 

 

1,397

 

 

 

404

 

 

 

1,736

 

 

 

605

 

Total share-based compensation expense

 

$

1,607

 

 

$

404

 

 

$

2,014

 

 

$

605

 

 

Share-based compensation expense by award type was as follows (in thousands):

 

 

 

Three Months Ended

 

 

Six Months Ended

 

 

 

June 30,

 

 

June 30,

 

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

Stock options

 

$

1,417

 

 

$

404

 

 

$

1,824

 

 

$

605

 

Restricted stock units

 

 

98

 

 

 

 

 

 

98

 

 

 

 

Employee stock purchase plan

 

 

92

 

 

 

 

 

 

92

 

 

 

 

Total share-based compensation expense

 

$

1,607

 

 

$

404

 

 

$

2,014

 

 

$

605